Healthcare

FDA takes bigger role in lowering drug prices

By Robert King
Published June 5, 2017 4:01am ET
Add Washington Examiner on Google
FDA takes bigger role in lowering drug prices
One of the moves Congress and the FDA are looking at is a loophole that major pharmaceutical companies use to stop generic makers from creating a cheaper copy. | malerapaso

The Food and Drug Administration isn’t standing on the sidelines anymore on fighting rising drug prices.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.

Tag:

Congress FDA House of Representatives Patrick Leahy Pharmaceutical Industry Robert King